Literature DB >> 17420741

Commercializing cognitive neurotechnology--the ethical terrain.

Margaret L Eaton1, Judy Illes.   

Abstract

Mesh：

Year:  2007        PMID： 17420741     DOI： 10.1038/nbt0407-393

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  12 in total

Review 1.  Bridging philosophical and practical implications of incidental findings in brain research.

Authors:  Judy Illes; Vivian Nora Chin
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

Review 2.  The brain, the science and the media. The legal, corporate, social and security implications of neuroimaging and the impact of media coverage.

Authors:  Garret O'Connell; Janet De Wilde; Jane Haley; Kirsten Shuler; Burkhard Schafer; Peter Sandercock; Joanna M Wardlaw
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

3.  Brain leaks and consumer neurotechnology.

Authors:  Marcello Ienca; Pim Haselager; Ezekiel J Emanuel
Journal:  Nat Biotechnol       Date:  2018-09-06       Impact factor: 54.908

Review 4.  Progress in Brain Computer Interface: Challenges and Opportunities.

Authors:  Simanto Saha; Khondaker A Mamun; Khawza Ahmed; Raqibul Mostafa; Ganesh R Naik; Sam Darvishi; Ahsan H Khandoker; Mathias Baumert
Journal:  Front Syst Neurosci       Date:  2021-02-25

Review 5.  Neurotalk: improving the communication of neuroscience research.

Authors:  Judy Illes; Mary Anne Moser; Jennifer B McCormick; Eric Racine; Sandra Blakeslee; Arthur Caplan; Erika Check Hayden; Jay Ingram; Tiffany Lohwater; Peter McKnight; Christie Nicholson; Anthony Phillips; Kevin D Sauvé; Elaine Snell; Samuel Weiss
Journal:  Nat Rev Neurosci       Date:  2009-12-02       Impact factor: 34.870

6.  In the mind's eye: provider and patient attitudes on functional brain imaging.

Authors:  J Illes; S Lombera; J Rosenberg; B Arnow
Journal:  J Psychiatr Res       Date:  2008-12       Impact factor: 4.791

7.  Brain-Computer Interfaces in Neurorecovery and Neurorehabilitation.

Authors:  Michael J Young; David J Lin; Leigh R Hochberg
Journal:  Semin Neurol       Date:  2021-03-19       Impact factor: 3.212

8.  Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics.

Authors:  Sebastian Sattler; Guido Mehlkop; Peter Graeff; Carsten Sauer
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-02-01

9.  Choice and Trade-offs: Parent Decision Making for Neurotechnologies for Pediatric Drug-Resistant Epilepsy.

Authors:  Viorica Hrincu; Patrick J McDonald; Mary B Connolly; Mark J Harrison; George M Ibrahim; Robert P Naftel; Winston Chiong; Armaghan Alam; Urs Ribary; Judy Illes
Journal:  J Child Neurol       Date:  2021-06-02       Impact factor: 1.987

10.  Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement.

Authors:  Sebastian Sattler; Cynthia Forlini; Eric Racine; Carsten Sauer
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.